Evommune | Chronic Inflammatory Disease Drugs

A proven team that has delivered for patients before and is ready to do it again.

Leadership

Evommune leadership is comprised of a seasoned group of professionals with decades of combined expertise across all stages of discovery, development, commercialization, and lifecycle management.

Management Board of Directors Scientific Advisory Board Investors

Luis Peña

President & Chief Executive Officer

Eugene A. Bauer, M.D.

Chief Medical Officer

Kyle Carver, M.B.A., C.P.A.

Chief Financial Officer

Gregory S. Moss, Esq.

Chief Business and Legal Officer

Jeegar Patel, Ph.D.

Chief Scientific Officer

Janice Drew, M.P.H.

Executive Vice President, Operations

Daniel J. Burge, M.D.

Senior Vice President, Clinical Development

Lou Sehl, Ph.D.

Senior Vice President, Technical Operations

Lorena Riol Blanco, Ph.D.

Vice President, Biology

Sam Chi, M.B.A.

Vice President, Commercial & Portfolio Planning

J. Mark Jackson, M.D.

Vice President, Clinical Development

Luis Peña

President & Chief Executive Officer

Eugene A. Bauer, M.D.

Chief Medical Officer

Kyle Carver, M.B.A., C.P.A.

Chief Financial Officer

Gregory S. Moss, Esq.

Chief Business and Legal Officer

Jeegar Patel, Ph.D.

Chief Scientific Officer

Janice Drew, M.P.H.

Executive Vice President, Operations

Daniel J. Burge, M.D.

Senior Vice President, Clinical Development

Lou Sehl, Ph.D.

Senior Vice President, Technical Operations

Lorena Riol Blanco, Ph.D.

Vice President, Biology

Sam Chi, M.B.A.

Vice President, Commercial & Portfolio Planning

J. Mark Jackson, M.D.

Vice President, Clinical Development

Benjamin F. McGraw, III, Pharm.D. (Chair of Board)

Chairman and Chief Executive Officer at TheraVida

David E. Cohen, M.D., M.P.H.

Professor of Dermatology, Vice Chairman of Clinical Affairs, Chief of Allergy and Contact Dermatitis, Director of Occupational and Environmental Dermatology

Derek DiRocco, Ph.D.

Partner, RA Capital Management

Eugene A. Bauer, M.D.

Chief Medical Officer

Felice Verduyn-van Weegen

Partner at EQT

François Beaubien, Ph.D., C.F.A.

Partner at Sectoral Asset Management

Luis Peña

President & Chief Executive Officer

Rob Hopfner, R.Ph., Ph.D., M.B.A.

Managing Partner at Pivotal bioVenture Partners

Yuexin Yu

Director at Andera Partners

Benjamin F. McGraw, III, Pharm.D. (Chair of Board)

Chairman and Chief Executive Officer at TheraVida

David E. Cohen, M.D., M.P.H.

Professor of Dermatology, Vice Chairman of Clinical Affairs, Chief of Allergy and Contact Dermatitis, Director of Occupational and Environmental Dermatology

Derek DiRocco, Ph.D.

Partner, RA Capital Management

Eugene A. Bauer, M.D.

Chief Medical Officer

Felice Verduyn-van Weegen

Partner at EQT

François Beaubien, Ph.D., C.F.A.

Partner at Sectoral Asset Management

Luis Peña

President & Chief Executive Officer

Rob Hopfner, R.Ph., Ph.D., M.B.A.

Managing Partner at Pivotal bioVenture Partners

Yuexin Yu

Director at Andera Partners

Dan R. Littman, M.D., Ph.D.

Professor of Molecular Immunology at the Skirball Institute of Biomolecular Medicine and Investigator of the Howard Hughes Medical Institute

Georg Stingl, M.D.

Professor Emeritus, Department of Dermatology, Medical University of Vienna

Mark G. Lebwohl, M.D.

Waldman Professor and Chairman, Dean for Clinical Therapeutics, Icahn School of Medicine at Mount Sinai

Brian Berman, M.D., Ph.D.

Professor Emeritus, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine

Emma Guttman-Yassky, M.D., Ph.D.

Sol and Clara Kest Professor of Dermatology and Immunology, Icahn School of Medicine at Mount Sinai

James G. Krueger, M.D., Ph.D.

Professor, Laboratory Head, The Rockefeller University

Russ B. Altman, M.D., Ph.D.

Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and, by courtesy, Computer Science, Stanford University

Stephen J. Galli, M.D.

Professor of Pathology and of Microbiology and Immunology, Stanford University

Dan R. Littman, M.D., Ph.D.

Professor of Molecular Immunology at the Skirball Institute of Biomolecular Medicine and Investigator of the Howard Hughes Medical Institute

Georg Stingl, M.D.

Professor Emeritus, Department of Dermatology, Medical University of Vienna

Mark G. Lebwohl, M.D.

Waldman Professor and Chairman, Dean for Clinical Therapeutics, Icahn School of Medicine at Mount Sinai

Brian Berman, M.D., Ph.D.

Professor Emeritus, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine

Emma Guttman-Yassky, M.D., Ph.D.

Sol and Clara Kest Professor of Dermatology and Immunology, Icahn School of Medicine at Mount Sinai

James G. Krueger, M.D., Ph.D.

Professor, Laboratory Head, The Rockefeller University

Russ B. Altman, M.D., Ph.D.

Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and, by courtesy, Computer Science, Stanford University

Stephen J. Galli, M.D.

Professor of Pathology and of Microbiology and Immunology, Stanford University

Partner with us to fight chronic inflammation.

Let's Collaborate